Phase I Study of Intravitreal Injection of Autologous CD34+ Stem Cells from Bone Marrow in Eyes with Vision Loss from Retinitis Pigmentosa.

Autor: Park SS; Department of Ophthalmology & Vision Science, University of California Davis Eye Center, Sacramento, California., Bauer G; Stem Cell Program, Institute for Regenerative Cures, University of California Davis Health, Sacramento, California., Fury B; Stem Cell Program, Institute for Regenerative Cures, University of California Davis Health, Sacramento, California., Abedi M; Division of Hematology Oncology and Malignant Hematology/Cellular Therapy and Transplantation, Department of Internal Medicine, University of California Davis Health, Sacramento, California., Perotti N; Stem Cell Program, Institute for Regenerative Cures, University of California Davis Health, Sacramento, California., Colead-Bergum D; Stem Cell Program, Institute for Regenerative Cures, University of California Davis Health, Sacramento, California., Nolta JA; Stem Cell Program, Institute for Regenerative Cures, University of California Davis Health, Sacramento, California.; Division of Hematology Oncology and Malignant Hematology/Cellular Therapy and Transplantation, Department of Internal Medicine, University of California Davis Health, Sacramento, California.

Publikováno v: Ophthalmology science [Ophthalmol Sci] 2024 Jul 31; Vol. 5 (1), pp. 100589. Date of Electronic Publication: 2024 Jul 31 (Print Publication: 2025).